Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
E For L Aim PCLBKK:EFORL 36 EV-to-FCF is 8.14 as of Aug. 02, 2026, which is 33% above its 10-year median of 6.12. GuruFocus rates BKK:EFORL with a GF Score™ of 36/100 and a GF Value™ of ฿0.15 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 72 Medical Distribution companies, E For L Aim PCL ranks better than 75% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, E For L Aim PCL's Enterprise Value is ฿735 Mil.
E For L Aim PCL's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was ฿90 Mil. Therefore, E For L Aim PCL's EV-to-FCF for today is 8.14.
The historical rank and industry rank for E For L Aim PCL's EV-to-FCF or its related term are showing as below:
BKK:EFORL'
s EV-to-FCF Range Over the Past 10 Years
Min: -2375.83 Med: 6.12 Max: 307.26
Current: 8.59
During the past 13 years, the highest EV-to-FCF of E For L Aim PCL was 307.26. The lowest was -2375.83. And the median was 6.12.
BKK:EFORL's EV-to-FCF is ranked better than 75% of 72
companies
in the Medical Distribution industry
Industry Median: 17.36
vs BKK:EFORL: 8.59
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
E For L Aim PCL's PE Ratio (TTM) for today is calculated as:
E For L Aim PCL's share price for today is ฿0.12.
E For L Aim PCL's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿0.012.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
E For L Aim PCL EV-to-FCF Related Terms
E For L Aim PCL EV-to-FCF Historical Data
* Premium members only.
The historical data trend for E For L Aim PCL's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, E For L Aim PCL's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
E For L Aim PCL EV-to-FCF vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, E For L Aim PCL's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where E For L Aim PCL's EV-to-FCF falls into.
E For L Aim PCL's current Enterprise Value is ฿735 Mil.
E For L Aim PCL's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿90 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
E For L Aim PCL (BKK:EFORL) has a EV-to-FCF of 8.14 as of Aug. 02, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on E For L Aim PCL and its competitors. This is 33% above median its historical median of 6.12. According to the industry distribution chart, E For L Aim PCL ranks #18 out of 72 companies in the Medical Distribution industry, placing it in the top 25%.
Is E For L Aim PCL's EV-to-FCF too high?
E For L Aim PCL's current EV-to-FCF of 8.14 is 33% above median its 10-year median of 6.12. The Medical Distribution industry median EV-to-FCF is 17.36. E For L Aim PCL's value of 8.14 is 53.1% below this industry median. Based on the distribution chart, E For L Aim PCL ranks #18 out of 72 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, E For L Aim PCL has a GF Score™ of 36/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does E For L Aim PCL's EV-to-FCF compare to MCK and COR?
According to the Medical Distribution industry distribution chart, E For L Aim PCL ranks #18 out of 72 companies for EV-to-FCF. This places E For L Aim PCL in the top 25% of its industry — outperforming the majority of peers. The industry median EV-to-FCF is 17.36. E For L Aim PCL's value of 8.14 is 53.1% below this benchmark. While the company's 10-year median is 6.12 vs. the industry median of 17.36, E For L Aim PCL has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Distribution company?
The median EV-to-FCF among Medical Distribution companies is 17.36, based on 72 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. E For L Aim PCL's current EV-to-FCF of 8.14 is 53.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on E For L Aim PCL and its competitors. For the Medical Distribution industry, the median EV-to-FCF is 17.36 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. E For L Aim PCL's current EV-to-FCF is 8.14, which is 33% above median its own 10-year median of 6.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is E For L Aim PCL stock overvalued right now?
Based on GuruFocus' analysis, E For L Aim PCL (BKK:EFORL) is currently considered Modestly Undervalued. The stock's GF Value™ is ฿0.15, compared to a current price of ฿0.12 — trading 20% below its estimated fair value. The current EV-to-FCF is 8.14, which is 33% above median its 10-year median of 6.12 and 53.1% below the Medical Distribution industry median of 17.36. E For L Aim PCL's overall GF Score™ is 36/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For E For L Aim PCL (BKK:EFORL), the current EV-to-FCF is 8.14 as of Aug. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is E For L Aim PCL (BKK:EFORL) Overvalued in 2026?
Based on GuruFocus' analysis, E For L Aim PCL stock appears to be undervalued.
The current stock price of ฿0.12 is trading 20% below its estimated GF Value™ of ฿0.15.
GuruFocus considers E For L Aim PCL to be Modestly Undervalued.
Key valuation signals for BKK:EFORL:
EV-to-FCF: 8.14 (33% above median its 10-year median of 6.12)
GF Value™: ฿0.15 vs. price of ฿0.12 (20% below fair value)
Industry Position: 53.1% below the Medical Distribution median (#18 of 72)
No single metric tells the full story. See the BKK:EFORL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
E For L Aim PCL is engaged in the distribution of medical devices and equipment. The company and subsidiary have distributor agreements for medical devices and equipment with foreign companies. Its products include Patient Monitor System, Central Monitors System, Defibrillator, Automated External Defibrillator (AED), Electrocardiographs, Electroencephalogram (EEG), PSG System (Sleep Labs), and Accessories and Consumables. The group is principally engaged in one operating segment which is the distribution of medical device and equipment and providing service of medical equipment. Their operations are carried out in Thailand.
36GF Score
Get the complete analysis for BKK:EFORL
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:EFORL has been successfully added to your 
